We’ve all heard the saying “prevention is better than cure” but it seems that that is not true for the focus of diabetes research. We already know that when patients get on treatment for many diseases, such as diabetes, they may stay on the drugs that are prescribed for the rest of their lives.
Many critics of the “healthcare” industry point out that it is not profitable to “cure” diseases like diabetes but instead “manage” them with drugs. When diseases are “managed”, drug companies benefit by being able to sell them the drugs they need, as opposed to when they get cured from the disease.
According to a Duke University study, diabetes research emphasizes drug therapies more than preventive measures to combat the disease.
The current research also tends to leave out older adults and children, who could benefit substantially from better disease management.
The findings, published in the journal Diabetologia, suggest that current research efforts may not sufficiently study diabetes prevention, management or therapeutic safety.
The authors of the study examined nearly 2,500 diabetes-related trials from 2007 to 2010. They found that of the 2,484 trials correlated with diabetes, 75 percent emphasized diabetes treatment while only 10 percent were conducted to examine preventive measures. Sixty-three percent of the trials involved a drug and 12 percent involved behavioral tests.
“It’s important that clinical trials enroll patients who are representative of populations affected by diabetes and its complications,” study researcher Dr. Jennifer Green, M.D, an associate professor at Duke University School of Medicine and a member of the Duke Clinical Research Institute, explained in a statement. “Our study is just a snapshot in time, but it can serve as a guide for where we need to focus attention and resources.”
The study also found that most clinical trials assessed small numbers of patients in a constrained number of locations. Many trials took only two years to complete and did not seem to exhibit a geographical mix of diabetes patients.